- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV2 variant (Y444F) vector system (retina-validated AAV expression and packaging plasmid system) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi (GM) AAV2 variant (Y444F) Vector system is including: 1) AAV2 variant (Y444F) Rep-Cap plasmid (AAV2 variant (Y444F)-RC plasmid) 2) AAV Helper plasmid 3) AAV expression vectors (overexpression or shRNA).
You can produce AAV2 variant (Y444F) particle in 293T cell line in high titer using GeneMedi's AAV2 variant (Y444F) Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
The tissue tropism of AAV2 variant (Y444F) vector has been validated in retina (retinal ganglion cells) by both intravitreal injection and sub-retinal injection., with potential applications in retina gene therapy.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids, AAV expression Plasmids and AAV helper Plasmid.
Go to AAV
vector system
>>
Map Download
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | ||
|---|---|---|---|---|---|
| P-PK03 | AAV2 variant(Y444F)Vector System (Amp resistance) 1. AAV2 variant (Y444F) Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 3024 | ||
| P-PK03 | AAV2 variant(Y444F)Vector System (Amp resistance) 1. AAV2 variant (Y444F) Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Biotech & Pharma & Medical Device & Diagnostics | |||
| P-PK03 | AAV2 variant(Y444F)Vector System (Amp resistance) 1. AAV2 variant (Y444F) Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-PK03 | AAV2 variant(Y444F)Vector System (Amp resistance) 1. AAV2 variant (Y444F) Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK03-Kan | AAV2 variant(Y444F)Vector System (Kan resistance) 1. AAV2 variant (Y444F) Rep-Cap Plasmid (Kan resistance) , ≥10mg 2. AAV Helper Plasmid (Kan resistance) , ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-RC03 | AAV2 variant(Y444F)Rep-Cap
Plasmid (Amp resistance)
Size：5ug |
Academic | 1719 | ||
| P-RC03 | AAV2 variant(Y444F)Rep-Cap
Plasmid (Amp resistance)
Size：5ug | Biotech & Pharma & Medical Device & Diagnostics | |||
| P-RC03 | AAV2 variant(Y444F)Rep-Cap
Plasmid (Amp resistance)
Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-RC03 | AAV2 variant(Y444F)Rep-Cap
Plasmid (Amp resistance)
Size：≥10mg |
All | |||
| P-RC03-Kan | AAV2 variant(Y444F)Rep-Cap
Plasmid(Kan resistance)
Size：≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Vector System. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Vector System currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| Moderate UV Exposure Enhances Learning and Memory by Promoting a Novel Glutamate Biosynthetic Pathway in the Brain | CELL | 2018/6/14 |
| Hepatic glucuronyl C5-epimerase combats obesity by stabilising GDF15 | Journal of Hepatology | 2023/5/20 |
| SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)–Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation | Circulation | 2020/3/24 |
| Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus | signal transduction and targeted therapy | 2022/2/18 |
| shear stress-induced cellular senescence blunts liver regeneration through Notch-Sirt1-P21/P16 axis | Hepatology | 2021/10/23 |
| [PDF] TIMP2 ameliorates blood–brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-Cadherin internalization | JOURNAL OF CLINICAL INVESTIGATION | 2023/11/28 |
| Epigenetic controls of Sonic hedgehog guarantee fidelity of epithelial adult stem cells trajectory in regeneration | Science Advances | 2022/7/22 |
| FoxO3 restricts liver regeneration by suppressing the proliferation of hepatocytes | npj Regenerative Medicine | 2022/6/24 |
| KPT330 promotes the sensitivity of glioblastoma to olaparib by retaining SQSTM1 in the nucleus and disrupting lysosomal function | Autophagy | 2023/9/15 |
| SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation | Journal of Experimental & Clinical Cancer Research | 2023/9/8 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
